About SOVR Health
Redefining preventive health
one blood test at a time
We believe “normal” lab results shouldn’t be the finish line. SOVR combines AI-powered biomarker analysis with physician oversight to help you find disease before it finds you.
Built because I almost missed it
At 32, I felt invincible. My annual physical came back “normal.” Six months later, I was in the ER with a pulmonary embolism. A simple ApoB test — not included in standard panels — would have flagged the risk years earlier.
That experience changed everything. I spent two years studying longevity medicine, working with researchers at Stanford and AstraZeneca, and building the platform I wish I’d had: one that screens for 2,259 diseases from a single blood draw, predicts your trajectory 20 years out, and puts a board-certified physician on your team.
SOVR exists so no one else has to learn the hard way that “normal” isn’t the same as “optimal.”
50+
Combined years in healthcare & AI
12
Team members, 4 MDs
3
Peer-reviewed models integrated
Xieyuhang — Founder & CEO
Our Mission
Make longevity medicine accessible to everyone
Executive health clinics charge $20,000+/year for comprehensive biomarker testing. We believe this level of care should be available to everyone, not just the wealthy.
Transparency First
Every recommendation is backed by peer-reviewed research. We cite our sources and never hide behind proprietary black boxes.
Science Over Hype
Our algorithms are built on validated models — PhenoAge, MILTON, Delphi-2M — not marketing buzzwords.
Patient-Centered
Every health plan is reviewed by a board-certified physician before it reaches you. No exceptions.
Accessible to All
What used to cost $20,000/year at executive health clinics is now available starting at $49/month.
Our Science
Three peer-reviewed models. One platform.
MILTON
2,259
Diseases screened from blood biomarkers
Based on AstraZeneca research. Published in Nature Genetics, 2024.
Read paperDelphi-2M
20-Year
Health trajectory prediction
Trained on 2M+ patient records from Google Health. Predicts disease onset decades in advance.
PhenoAge
Biological Age
Your true age vs. chronological age
Levine et al. Aging, 2018. Validated epigenetic aging clock using standard blood biomarkers.
Read paperMedical Advisory Board
Led by physicians, not marketers
Every health plan is reviewed by our board-certified medical team before it reaches you.
Dr. James Mitchell
Chief Medical Officer
Harvard Medical School
Board-certified in internal and preventive medicine with 18 years of clinical experience. Oversees all physician-reviewed protocols and ensures evidence-based supplement recommendations.
Dr. Priya Sharma
Head of Research
Stanford University
Published researcher in cellular senescence and epigenetic aging clocks. Leads the scientific validation of SOVR's PhenoAge-based biological age algorithm.
Dr. Nathan Khalil
Neuroscience Advisor
MIT / Johns Hopkins
Neuroscientist specializing in neuroinflammation and cognitive decline biomarkers. Advises on brain-health supplement protocols and neuroprotective interventions.
Dr. Catherine Park
Cardiology Advisor
Mayo Clinic
Interventional cardiologist with expertise in lipid management and metabolic syndrome. Reviews cardiovascular risk protocols and statin recommendation thresholds.
Our Journey
From ER visit to Y Combinator
2024
Founded after personal health scare. Research begins with Stanford & AstraZeneca collaborators.
2025
MILTON & Delphi-2M models integrated. Advisory board formed. First 500 beta members.
2026
Y Combinator W26. Launch of full platform with 2,259-disease screening and 20-year trajectory prediction.
Trust & Compliance
Your data is sacred
HIPAA
Compliant
SOC 2
Type II Certified
CLIA
Certified Labs
CAP
Accredited
All health data is encrypted at rest and in transit. PHI is stored in HIPAA-compliant infrastructure powered by Medplum FHIR. We never sell your data.
Ready to take control of your health?
Join 2,847+ members who chose optimal over normal.